跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
New Ambiceph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
New Ambiceph
Approved
STANDARD
New Ambiceph
Brawn Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8bb8c5c221b88f2e
Company
Brawn Laboratories Limited
Type
Standard
Approval Details
Approval Id
8bb8c5c221b88f2e
Drug Approval Philippines Name
New Ambiceph
Product Name
New Ambiceph
Registration Number
DRP-4474-01
Brand Name
New Ambiceph
Generic Name
Ceftriaxone (as sodium)
Dosage Form
Powder for Injection (IM/IV)
Dosage Strength
1g
Manufacturer
Brawn Laboratories Limited
Importer
Ambica International Trading Corp.
Distributor
MMG-FED Pharma
Issuance Date
26 October 2022
Expiry Date
13 June 2028
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8bb8c5c221b88f2e
Type
Standard
Back to Philippines FDA Approvals